Effect of eel galectin AJL-1 on periodontopathic bacterial biofilm formation and their lipopolysaccharide-mediated inflammatory cytokine induction.
Porphyromonas gingivalis, Prevotella intermedia and Aggregatibacter actinomycetemcomitans, infectious pathogenic bacteria found in oral biofilm, cause periodontal disease. The inhibitory effect of AJL-1, a galectin present in the skin mucus of the Japanese eel Anguilla japonica, on biofilm formation by each of these strains was investigated by staining adherent bacteria on culture plates with crystal violet. An ATP bioluminescence assay was used to determine whether inhibition of biofilm formation was due to the bactericidal activity of AJL-1. The effect of AJL-1 on cytokine induction in human umbilical vascular endothelial cells (HUVECs) by lipopolysaccharide (LPS) isolated from A. actinomycetemcomitans was also investigated by enzyme-linked immunosorbent assay (ELISA). AJL-1 significantly inhibited biofilm formation by A. actinomycetemcomitans strains Y4, ATCC 29523 and ATCC 29524 but not by any strain of P. gingivalis or P. intermedia, and showed no bactericidal activity against A. actinomycetemcomitans strains. AJL-1 markedly suppressed interleukin (IL)-6 and IL-8 induction in HUVECs by LPS from A. actinomycetemcomitans strains Y4 and ATCC 29523. These observations indicate that AJL-1 is an effective inhibitor of biofilm formation by A. actinomycetemcomitans as well as of inflammatory cytokine induction in HUVECs by LPS. These finding indicate that AJL-1 may be of therapeutic value in A. actinomycetemcomitans-associated periodontal diseases.
Takayama
Saori
S
Department of Periodontology, Tokyo Dental College, 1-2-2 Masago, Mihama-ku, Chiba, Japan.
Saitoh
Eiichi
E
Kimizuka
Ryuta
R
Yamada
Satoru
S
Kato
Tetsuo
T
D016976:Aggregatibacter actinomycetemcomitans / Q000187:drug effects* / Q000254:growth & development; D000818:Animals; D018441:Biofilms / Q000187:drug effects*; D002478:Cells, Cultured; D016207:Cytokines / Q000187:drug effects / Q000276:immunology*; D004524:Eels; D042783:Endothelial Cells / Q000276:immunology; D037483:Galectin 1 / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000276:immunology; D008070:Lipopolysaccharides / Q000276:immunology / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests / Q000379:methods; D010510:Periodontal Diseases / Q000382:microbiology*; D016966:Porphyromonas gingivalis / Q000187:drug effects; D018713:Prevotella intermedia / Q000187:drug effects
D016207:Cytokines; D037483:Galectin 1; D008070:Lipopolysaccharides